Literature DB >> 26716022

Toll-Like Receptor-4 Dependent Small Intestinal Immune Responses Following Murine Arcobacter Butzleri Infection.

Markus M Heimesaat1, Gül Karadas2, André Fischer1, Ulf B Göbel1, Thomas Alter2, Stefan Bereswill1, Greta Gölz2.   

Abstract

Sporadic cases of gastroenteritis have been attributed to Arcobacter butzleri infection, but information about the underlying immunopathological mechanisms is scarce. We have recently shown that experimental A. butzleri infection induces intestinal, extraintestinal and systemic immune responses in gnotobiotic IL-10(-/-) mice. The aim of the present study was to investigate the immunopathological role of Toll-like Receptor-4, the receptor for lipopolysaccharide and lipooligosaccharide of Gram-negative bacteria, during murine A. butzleri infection. To address this, gnotobiotic IL-10(-/-) mice lacking TLR-4 were generated by broad-spectrum antibiotic treatment and perorally infected with two different A. butzleri strains isolated from a patient (CCUG 30485) or fresh chicken meat (C1), respectively. Bacteria of either strain stably colonized the ilea of mice irrespective of their genotype at days 6 and 16 postinfection. As compared to IL-10(-/-) control animals, TLR-4(-/-) IL-10(-/-) mice were protected from A. butzleri-induced ileal apoptosis, from ileal influx of adaptive immune cells including T lymphocytes, regulatory T-cells and B lymphocytes, and from increased ileal IFN-γ secretion. Given that TLR-4-signaling is essential for A. butzleri-induced intestinal inflammation, we conclude that bacterial lipooligosaccharide or lipopolysaccharide compounds aggravate intestinal inflammation and may thus represent major virulence factors of Arcobacter. Future studies need to further unravel the molecular mechanisms of TLR-4-mediated A. butzleri-host interactions.

Entities:  

Keywords:  Arcobacter butzleri; Toll-like Receptor-4; apoptosis; host-pathogen interactions; innate immunity; lipooligosaccharide; lipopolysaccharide; pro-inflammatory immune responses; small intestine; spleen

Year:  2015        PMID: 26716022      PMCID: PMC4681361          DOI: 10.1556/1886.2015.00042

Source DB:  PubMed          Journal:  Eur J Microbiol Immunol (Bp)        ISSN: 2062-509X


Introduction

The motile, spiral-shaped Gram-negative Arcobacter species belong to the Campylobacteraceae family and can be isolated from a plethora of environmental habitats, including surface water. In animals, for instance, Arcobacter spp. form part of the commensal gastrointestinal microbiota [1]. Among the 19 so far described Arcobacter spp., A. butzleri and A. cryaerophilus are regarded as hazards for human health by the International Commission on Microbiological Specifications for Foods [2]. Notaby, detection of Arcobacter spp. may fail in applied microbacteriological routine procedures [3]. Hence, prevalence and incidence of Arcobacter associated human diseases are not known yet and the reported cases rather underestimating the epidemiological situation. Nevertheless, several single clinical cases and outbreaks of arcobacteriosis are documented in the literature to date, hence providing evidence for an important role of Arcobacter spp. in causing intestinal disease [4, 5]. Retrospective studies revealed that Arcobacter spp. are the fourth most common Campylobacterales that could be isolated from diarrheal patients [6-8]. Patients are mostly likely infected by contaminated food or water [5, 9] and present with symptoms of acute gastroenteritis such as abdominal pain, acute diarrhea, or prolonged watery diarrhea for up to 2 months [6, 7]. However, information about the underlying mechanisms of infection and induced host immune responses is scarce. Phenotypic assays revealed adhesive, invasive, and cytotoxic effects of A. butzleri in vitro [10-17]. A. butzleri has been further shown to compromize barrier function in monolayers of the human colon cell line HT-29/B6 pointing towards potential mechanisms by which diarrhea might be induced in humans [18]. We have recently shown that, upon peroral A. butzleri infection, gnotobiotic IL-10–/– mice with a depleted commensal microbiota following broad-spectrum antibiotic treatment [19] could be stably infected by the bacterium and displayed significant small and large intestinal pro-inflammatory immune responses [20, 21]. Remarkably, infection-induced sequelae were not restricted to the intestinal tract, given that even systemic inflammatory responses could be observed in infected mice. Toll-like receptors (TLRs) are essentially involved in mediating innate immune responses of the host to commensals and pathogens [22]. Since bacterial lipopolysaccharides (LPS) and lipooligosaccharides (LOS) from Gram-negative bacteria are sensed by TLR-4 [22], we investigated the role of TLR-4 in mediating arcobacteriosis in vivo in the present study. To address this, IL-10 deficient mice lacking TLR-4 (TLR-4–/– IL-10–/–) were perorally infected either with A. butzleri reference strain CCUG 30485 (initially isolated from a diseased patient) [23] or C1 (derived from fresh chicken meat) [10], and the colonization and immunopathological properties of the respective bacterial strains were surveyed over time.

Materials and methods

Mice

IL-10–/– mice (in C57BL/10 background, B10) were bred and maintained in the facilities of the “Forschungseinrichtungen für Experimentelle Medizin” (FEM, Charité – Universitätsmedizin, Berlin, Germany) under specific pathogen-free (SPF) conditions. In order to generate TLR-4 IL-10 double deficient (TLR-4–/– IL-10–/–) mice, TLR-4–/– mice (in B10 background) were crossed to IL-10–/– mice and back crossed more than nine generations before use. To overcome physiological colonization resistance and assure stable pathogenic colonization, gnotobiotic TLR-4–/– IL-10–/– and IL-10–/– mice (with a virtually depleted gastrointestinal microbiota) were generated following broad-spectrum antibiotic treatment as described earlier [19, 24]. In brief, mice were transferred to sterile cages and treated by adding ampicillin–sulbactam (1 g/l; Pfizer, Berlin, Germany), vancomycin (500 mg/l; Hexal, Holzkirchen, Germany), ciprofloxacin (200 mg/l; Hexal), imipenem (250 mg/l; Fresenius Kabi, Graz, Austria), and metronidazole (1 g/l; Braun, Melsungen, Germany) to the drinking water ad libitum starting at 3 weeks of age immediately after weaning and continued for approximately 3 months before the infection experiment [25]. Three days prior infection, the antibiotic cocktail was replaced by sterile tap water (ad libitum). Germfree status of gnotobiotic mice was confirmed as described previously [24].

Arcobacter butzleri infection of mice

Age-matched female gnotobiotic TLR-4–/– IL-10–/– and IL-10–/– mice were perorally infected with approximately 109 viable colony forming units (CFU) of two different A. butzleri strains either (CCUG 30485 or C1 strain, respectively) by gavage in a total volume of 0.3 ml phosphate buffered saline (PBS) on two consecutive days (day 0 and day 1). Naive age- and sex-matched gnotobiotic TLR-4–/– IL-10–/– and IL-10–/– mice served as uninfected controls. The A. butzleri reference strain CCUG 30485 was initially isolated from a fecal sample derived from a diarrheal patient [23], whereas the C1 strain was isolated from fresh chicken meat [10]. Both A. butzleri strains were grown on Karmali-Agar (Oxoid, Wesel, Germany) for 2 days at 37 °C under microaerobic conditions using CampyGen gas packs (Oxoid) as described earlier [20, 21, 26].

Clinical score

To assess clinical signs of A. butzleri-induced infection on a daily basis, a standardized cumulative clinical score (maximum 12 points), addressing the occurrence of blood in feces (0: no blood; 2: microscopic detection of blood by the Guajac method using Haemoccult, Beckman Coulter/PCD, Krefeld, Germany; 4: overt blood visible), diarrhea (0: formed feces; 2: pasty feces; 4: liquid feces), and the clinical aspect (0: normal; 2: ruffled fur, less locomotion; 4: isolation, severely compromized locomotion, prefinal aspect), was used [19].

Sampling procedures

Mice were sacrificed by isofluran treatment (Abbott, Greifs wald, Germany) on day six or day 16 postinfection (p.i.). Tissue samples from mesenteric lymphnodes (MLNs), spleen, and ileum were removed under sterile conditions. Absolute small intestinal lengths were determined by measuring the distances from the transition of the stomach to the duodenum to the very distal terminal ileum by a ruler. Ileal ex vivo biopsies from each mouse were collected in parallel for immunohistochemical, microbiological, and immunological analyses. Immunohistopathological changes were determined in ileal samples immediately fixed in 5% formalin and embedded in paraffin. Sections (5 µm) were stained with hematoxylin and eosin (H&E) or respective antibodies for in situ immunohistochemistry as described earlier [25].

Histopathological grading of small intestinal lesions

To evaluate the severity of small intestinal histopathological lesions, an established scoring scheme with minor modifications was applied [27]. In detail, the character of immune cell infiltration (0: none; 1: mononuclear cells; 2: mononuclear cell dominated, fewer neutrophils; 3: neutrophil dominated, fewer mononuclear cells), quantity of immune cell infiltration (0: none; 1: mild; 2: moderate; 3: severe), vertical extent of inflammation (0: none; 1: mucosa; 2: mucosa and muscularis; 3: transmural), and horizontal extent of inflammation (0: no; 1: focal; 2: multifocal; 3: multifocal-coalescent; 4: diffuse) was assessed. The cumulative histologic scoring ranged from 0 to 13 for ileal samples.

Immunohistochemistry

In situ immunohistochemical analysis of ileal paraffin sections was performed as described previously [19, 26, 28–30]. Primary antibodies against cleaved caspase-3 (Asp175, Cell Signaling, Beverly, MA, USA, 1:200), F4/80 (no. 14-4801, clone BM8, eBioscience, 1:50), CD3 (no. N1580, Dako, 1:10), FOXP3 (FJK-16s, eBioscience, San Diego, CA, USA, 1:100), and B220 (eBioscience, 1:200) were used. The average number of positively stained cells within at least six high power fields (HPF, 0.287 mm2, 400× magnification) was determined for each mouse microscopically by a double-blinded investigator.

Quantitative analysis of A. butzleri

Viable A. butzleri was detected in luminal samples derived from the proximal (duodenum) and distal (ileum) part of the small intestines at days 6 or 16 p.i., dissolved in sterile PBS and cultured in serial dilutions on Karmali- and Columbia-Agar supplemented with 5% sheep blood (Oxoid) in parallel for 2 days at 37 °C under microaerobic conditions using CampyGen gas packs (Oxoid). To quantify bacterial translocation, MLNs and spleen (≈1 cm[2]) were homogenized in 1 ml sterile PBS, streaked onto Karmali-Agar and cultivated accordingly. The respective weights of fecal or tissue samples were determined by the difference of the sample weights before and after asservation. The detection limit of viable pathogens was ≈100 colony forming units (CFU) per g.

Cytokine detection in culture supernatants of ex vivo biopsies taken from ileum, mesenteric lymphnodes, and spleen

Ileal ex vivo biopsies were cut longitudinally and washed in PBS. Spleen, MLNs, or strips of approximately 1 cm[2] ileum were placed in 24-flat-bottom well culture plates (Nunc, Wiesbaden, Germany) containing 500 µl serum-free RPMI 1640 medium (Gibco, Life Technologies, Paisley, UK) supplemented with penicillin (100 U/ml) and streptomycin (100 µg/ml; PAA Laboratories). After 18 h at 37 °C, culture supernatants were tested for IFN-γ by the Mouse Inflammation Cytometric Bead Assay (CBA; BD Biosciences, San Jose, CA, USA) on a BD FACSCanto II flow cytometer (BD Biosciences).

Statistical analysis

Medians and levels of significance were determined using Mann-Whitney U test (GraphPad Prism v5, La Jolla, CA, USA). Two-sided probability (P) values ≤ 0.05 were considered significant. Experiments were reproduced twice.

Ethics statement

All animal experiments were conducted according to the European Guidelines for animal welfare (2010/63/EU) with approval of the commission for animal experiments headed by the “Landesamt für Gesundheit und Soziales” (LaGeSo, Berlin, registration number G0184/12). Animal welfare was monitored twice daily by assessment of clinical conditions.

Results

Colonization properties of A. butzleri strains in small intestines of gnotobiotic IL-10–/– mice lacking TLR-4

Gnotobiotic IL-10–/– mice lacking TLR-4 (TLR-4–/– IL-10–/–) and gnotobiotic IL-10–/– control mice with a virtually depleted intestinal microbiota were generated by broad-spectrum antibiotic treatment and perorally infected with A. butzleri strains CCUG 30485 or C1. Six and 16 days following A. butzleri infection bacterial concentrations of either strain did not differ in the proximal (i.e., duodenum) and distal (i.e., ileum) part of the small intestines of TLR-4–/– IL-10–/– and IL-10–/– mice (. Irrespective of the bacterial strain and time point p.i., mice of either genotype harbored approximately 103 to 105 CFU per gram A. butzleri in their ileal lumen (. Notably, neither in MLN nor in spleen, viable A. butzleri could be detected in infected mice of either genotype at days 6 or 16 p.i. by direct plating (not shown).

Clinical aspects and intestinal apoptosis induced by A. butzleri in gnotobiotic IL-10–/– mice lacking TLR-4

Despite intestinal colonization, however, infected mice of either genotype did not exhibit any clinical signs of enteric disease such as wasting, diarrhea, or occurence of blood in stool, neither early (i.e., at day 6 p.i.) nor later (i.e., day 16 p.i.) in the course of A. butzleri infection with either strain (not shown). Since intestinal inflammation leads to significant shortening of the intestinal tract [19, 24], we assessed small intestinal lengths at days of necropsy. Neither at day 6 nor at day 16 following A. butzleri infection with either strain, shortening of the small intestines in infected gnotobiotic TLR-4–/– IL-10–/– or IL-10–/– mice could be observed when compared to uninfected control animals (not shown), thus, further supporting absence of macroscopic disease. We next surveyed potential microscopic intestinal sequelae of infection in H&E stained small intestinal paraffin sections applying a standardized histopathological scoring system. Histopathological scores did not differ between naive and infected TLR-4–/– IL-10–/– and IL-10–/– mice, irrespective of the applied strain and time point p.i. (not shown). Given that apoptosis is a commonly used diagnostic marker in the histopathological evaluation and grading of intestinal inflammation and a hallmark of C. jejuni-induced enterocolitis in gnotobiotic IL-10–/– mice [19], we next assessed numbers of caspase-3+ cells within the small intestinal mucosa of infected mice. Numbers of apoptotic ileal epithelial cells increased in IL-10–/– mice until day 16 following infection with either strain (p < 0.005; and ). However, TLR-4–/– IL-10–/– mice exhibited lower apoptotic cell numbers than IL-10–/– control animals at day 16 following A. butzleri strain CCUG 30485 infection (p < 0.005; ; ). Furthermore, apoptotic cell numbers were lower in the ileal mucosa of TLR-4–/– IL-10–/– as compared to IL-10–/– mice at days 6 and 16 following C1 strain infection (p < 0.05; ), and relative infection-induced increases were less pronounced in mice of the former genotype (. Taken together, despite lack of clinical and histopathological changes, TLR-4 gene deficiency was associated with lower abundances of ileal apoptotic cells during A. butzleri infection with either strain.

Role of TLR-4 in small intestinal inflammation induced by A. butzleri in gnotobiotic IL-10–/– mice

Given that recruitment of innate and adaptive immune cells as well as of effector cells to sites of inflammation is a hallmark of enteric infection including campylobacteriosis, we next quantitatively determined distinct immune cell populations by in situ immunohistochemical staining of small intestinal paraffin sections. Interestingly, already in the naive state, TLR-4–/– IL-10–/– mice exhibited lower numbers of F4/80+ macrophages and monocytes as compared to IL-10–/– mice (p < 0.005; ), which also held true at day 6 following infection with either strain (p < 0.0005 and p < 0.005, respectively; ). Six and 16 days following A. butzleri strain C1 infection, F4/80+ cell numbers increased in the ileal mucosa of TLR-4–/– IL-10–/– mice (p < 0.05 and p < 0.005, respectively; ), whereas ileal macrophages and monocytes increased as early as 6 days following A. butzleri CCUG 30485 strain infection in TLR-4–/– IL-10–/– mice only (p < 0.05; ). As compared to uninfected mice, numbers of CD3+ T lymphocytes were higher in small intestines of IL-10–/– than TLR-4–/– IL-10–/– mice at days 6 and 16 p.i. with either strain (p < 0.05–0.0005; ). Furthermore, A. butzleri induced relative increases in T lymphocytes were less pronounced in TLR-4–/– IL-10–/– as compared to IL-10–/– mice (). Ileal Treg numbers increased in IL-10–/– but not TLR-4–/– IL-10–/– mice until days 6 and 16 following A. butzleri CCUG 30485 strain infection (p < 0.05; , left panel; ). At day 16, but not day 6 following A. butzleri C1 strain infection, only IL-10–/– mice displayed higher Tregs in their small intestines as compared to uninfected control animals (p < 0.05; , right panel; ). Furthermore, Treg numbers were higher in small intestines of IL-10–/– mice at day 6 following A. butzleri CCUG 30485 strain as compared to C1 strain infection (p < 0.05; ). As for the innate F4/80+ cells, naive as well as infected TLR-4–/– IL-10–/– mice exhibited lower ileal B220+ B lymphocytes as compared to respective IL-10–/– control mice (p < 0.05– 0.0001; ). Only 16 days following A. butzleri strain C1 infection, elevated B220+ cells could be determined in the ilea of IL-10–/– mice (p < 0.005; , right panel; ) that were significantly higher as compared to those observed in A. butzleri CCUG 30485 strain infected mice at day 6 (p < 0.01; ). Taken together, TLR-4–/– IL-10–/– mice exhibited lower numbers of ileal innate and adaptive immune cell populations following A. butzleri infection with either strain.

Small intestinal and systemic pro-inflammatory cytokine levels in A. butzleri-infected gnotobiotic IL-10–/– mice lacking TLR-4

We next measured concentrations of the pro-inflammatory cytokine IFN-γ in supernatants of ex vivo biopsies derived from ileum, MLN, and spleen. Irrespective of the applied strain, ileal IFN-γ concentration significantly increased as early as 6 days following A. butzleri infection of IL-10–/–, but not TLR-4–/– IL-10–/– mice (p < 0.005 and p < 0.05, respectively; ). At day 6 p.i., IFN-γ concentrations were higher in small intestines of A. butzleri CCUG 30485 strain as compared to C1 strain infected IL-10–/– mice (p < 0.05; ). Six days following A. butzleri CCUG 30485 strain infection, IFN-γ levels increased in MLNs of mice of either genotype, but less distinctly in IL-10–/– mice lacking TLR-4 (p < 0.005 and p < 0.05; ). There was, however, a trend towards lower IFN-γ concentrations in MLN of IL-10–/– mice lacking TLR-4 as compared to IL-10–/– control animals (n.s.; ). Interestingly, no significant increases of the pro- inflammatory cytokine could be observed in MLN at either time point following A. butzleri C1 strain infection, ir respective of the genotype of mice (. Remarkably, pro-inflammatory cytokine responses were not restricted to the intestinal tract, given that IFN-γ concentrations significantly increased in spleens of IL-10–/– versus TLR-4–/– IL-10–/– mice as early as 6 days following CCUG 30485 strain infection (p < 0.005; ), but declined back to naive levels until day 16 p.i. (. At day 6 p.i., splenic IFN-γ concentrations were lower in C1 strain as compared to CCUG 30485 strain infected IL-10–/– mice (p < 0.05; ). Interestingly, IFN-γ concentrations were higher in spleens of TLR-4–/– IL-10–/– as compared to IL-10–/– mice at day 16 following A. butzleri infection with either strain (p < 0.005; ). In TLR-4–/– IL-10–/– mice, however, splenic IFN-γ levels measured at day 16 p.i. did not differ from uninfected, naive mice (. Taken together, A. butzleri-induced IFN-γ production was strain dependent, but less pronounced in the small intestinal compartment of IL-10–/– mice lacking TLR-4–/–.

Discussion

The immunopathological impact of A. butzleri infection in vivo is under current debate. Data regarding the molecular mechanisms underlying potential host interactions with this emerging pathogen are lacking due to the scarcity of appropriate in vivo models [20]. In the present study, we have applied our gnotobiotic (i.e., secondary abiotic) IL-10–/– mouse infection model in order to unravel the role of TLR-4, the major innate immune receptor for sensing of LPS and LOS derived from the cell wall of Gram-negative bacteria, in murine Arcobacter infection. Both gnotobiotic IL-10–/– mice lacking TLR-4 and gnotobiotic IL-10–/– control animals harbored comparable A. butzleri loads in their proximal (i.e., duodenum) and distal (i.e., ileum) small intestines following peroral infection. The small intestinal colonization potential of A. butzleri was strain-independent, given that either strain colonized the proximal as well as distal small intestines of gnotobiotic mice at comparably high concentrations. Interestingly, A. butzleri strain-dependent differences in infection-induced immune cell responses could be observed in IL-10–/– control, but not IL-10–/– mice lacking TLR-4. For instance, small intestinal Treg numbers were lower at day 6 following C1 versus CCUG 30485 strain infection, whereas at day 16 p.i., B cell counts were higher in ilea of C1 as compared to CCUG 30485 strain-infected IL-10–/– mice. Remarkably, TLR-4 was essential for A. butzleri-induced ileal apoptosis and inflammatory immune cell responses as indicated by lower numbers of ileal T lymphocytes, Tregs and B cells as well as less distinct small intestinal pro-inflammatory IFN-γ secretion in infected IL-10–/– mice lacking TLR-4. Surprisingly, splenic IFN-γ concentrations were even higher in TLR-4–/– IL-10–/– as compared to IL-10–/– control mice 16 but not 6 days following A. butzleri infection with either strain. Notably, viable bacteria could not be detected in extra-intestinal and systemic compartments including the spleen by direct plating in infected mice of either genotype. It is tempting to speculate that, in the course of the systemic immune response upon infection, more immune cells such as dendritic cells and lymphocytes might have been imprinted and activated in the spleen of IL-10–/– mice lacking TLR-4 as compared to control mice. The TLR-4 dependence of local (i.e., small intestinal) pro-inflammatory immune responses in A. butzleri infected mice is well in line with results from our C. jejuni in vivo studies demonstrating that C. jejuni-induced colonic and extra-intestinal disease is mediated by TLR-4 signalling of pathogenic LOS [19, 26, 31]. The structure of the carbohydrate backbone of LOS has been successfully characterized in the halophilic bacterium A. halophilus [32]. To date, however, molecular structures of neither LPS nor LOS have been identified in A. butz leri. It is highly likely, however, that, besides TLR-4, other so far unknown pattern recognition factors including TLR and NOD-like receptors are involved in mediating Arcobacter infection. For murine C. jejuni infection, for instance, we were able to demonstrate that, in addition to TLR-4- dependent signalling of C. jejuni LOS, sensing of pathogenic lipoproteins and CpG-DNA by TLR-2 and -9, respectively, contributed to infection-induced pro-inflammatory sequelae [19, 26]. Taken together, we here show that TLR-4 is essential for pro-inflammatory immune responses induced by A. butzleri in the small intestinal tract of infected mice. In conclusion, further in vivo studies should further elucidate the molecular mechanisms underlying pathogen–host interactions in arcobacteriosis.
  30 in total

Review 1.  Innate immune recognition.

Authors:  Charles A Janeway; Ruslan Medzhitov
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

2.  The structure of the carbohydrate backbone of the lipooligosaccharide from the halophilic bacterium Arcobacter halophilus.

Authors:  Alba Silipo; Luisa Sturiale; Vincenzo Perino; Domenico Garozzo; Rosa Lanzetta; Michelangelo Parrilli; Antonio Molinaro
Journal:  Carbohydr Res       Date:  2010-01-28       Impact factor: 2.104

3.  An outbreak of foodborne illness among attendees of a wedding reception in Wisconsin likely caused by Arcobacter butzleri.

Authors:  Victoria Lappi; John R Archer; Elizabeth Cebelinski; Fe Leano; John M Besser; Rachel F Klos; Carlota Medus; Kirk E Smith; Collette Fitzgerald; Jeffrey P Davis
Journal:  Foodborne Pathog Dis       Date:  2013-02-04       Impact factor: 3.171

4.  Determination of the occurrence of Arcobacter butzleri in beef and dairy cattle from Texas by various isolation methods.

Authors:  Steven C Golla; Elsa A Murano; Lee G Johnson; Norlyn C Tipton; Erin A Cureington; Jeff W Savell
Journal:  J Food Prot       Date:  2002-12       Impact factor: 2.077

5.  Isolation of Arcobacter spp. from retail meats and cytotoxic effects of isolates against vero cells.

Authors:  A Villarruel-López; M Márquez-González; L E Garay-Martínez; H Zepeda; A Castillo; L Mota de la Garza; E A Murano; R Torres-Vitela
Journal:  J Food Prot       Date:  2003-08       Impact factor: 2.077

6.  Survey of extra-intestinal immune responses in asymptomatic long-term Campylobacter jejuni-infected mice.

Authors:  Markus M Heimesaat; Lea-Maxie Haag; André Fischer; Bettina Otto; Anja A Kühl; Ulf B Göbel; Stefan Bereswill
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-09-23

7.  Novel murine infection models provide deep insights into the "ménage à trois" of Campylobacter jejuni, microbiota and host innate immunity.

Authors:  Stefan Bereswill; André Fischer; Rita Plickert; Lea-Maxie Haag; Bettina Otto; Anja A Kühl; Javid I Dasti; Javid I Dashti; Andreas E Zautner; Melba Muñoz; Christoph Loddenkemper; Uwe Gross; Ulf B Göbel; Markus M Heimesaat
Journal:  PLoS One       Date:  2011-06-15       Impact factor: 3.240

8.  Campylobacter jejuni induces acute enterocolitis in gnotobiotic IL-10-/- mice via Toll-like-receptor-2 and -4 signaling.

Authors:  Lea-Maxie Haag; André Fischer; Bettina Otto; Rita Plickert; Anja A Kühl; Ulf B Göbel; Stefan Bereswill; Markus M Heimesaat
Journal:  PLoS One       Date:  2012-07-10       Impact factor: 3.240

9.  Arcobacter species in humans.

Authors:  Olivier Vandenberg; Anne Dediste; Kurt Houf; Sandra Ibekwem; Hichem Souayah; Sammy Cadranel; Nicole Douat; G Zissis; J-P Butzler; P Vandamme
Journal:  Emerg Infect Dis       Date:  2004-10       Impact factor: 6.883

10.  Arcobacter butzleri: underestimated enteropathogen.

Authors:  Valérie Prouzet-Mauléon; Leila Labadi; Nathalie Bouges; Armelle Ménard; Francis Mégraud
Journal:  Emerg Infect Dis       Date:  2006-02       Impact factor: 6.883

View more
  4 in total

1.  The Immunopathogenic Potential of Arcobacter butzleri - Lessons from a Meta-Analysis of Murine Infection Studies.

Authors:  Greta Gölz; Thomas Alter; Stefan Bereswill; Markus M Heimesaat
Journal:  PLoS One       Date:  2016-07-20       Impact factor: 3.240

2.  Immune Responses to Broad-Spectrum Antibiotic Treatment and Fecal Microbiota Transplantation in Mice.

Authors:  Ira Ekmekciu; Eliane von Klitzing; Ulrike Fiebiger; Ulrike Escher; Christian Neumann; Petra Bacher; Alexander Scheffold; Anja A Kühl; Stefan Bereswill; Markus M Heimesaat
Journal:  Front Immunol       Date:  2017-04-19       Impact factor: 7.561

3.  Toll-Like Receptor-4 Dependent Intestinal Gene Expression During Arcobacter Butzleri Infection of Gnotobiotic Il-10 Deficient Mice.

Authors:  Greta Gölz; Thomas Alter; Stefan Bereswill; Markus M Heimesaat
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2016-03-28

4.  Intestinal Expression of Genes Encoding Inflammatory Mediators and Gelatinases During Arcobacter Butzleri Infection of Gnotobiotic Il-10 Deficient Mice.

Authors:  Markus M Heimesaat; Thomas Alter; Stefan Bereswill; Greta Gölz
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2016-03-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.